Showing results (431-440 of 456) with videos related to

Sort By:
Pageof 46
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 10, 2019
Extended delivery of vaccines to the skin improves immune responsesJessica C Joyce, Hila E Sella, Heather Jost, et al.
Nano Letters|January 4, 2021
Bifunctional Janus Particles as Multivalent Synthetic Nanoparticle Antibodies (SNAbs) for Selective Depletion of Target CellsJiaying Liu, Randall Toy, Casey Vantucci, et al.
Plos Pathogens|January 14, 2021
Carbomer-based adjuvant elicits CD8 T-cell immunity by inducing a distinct metabolic state in cross-presenting dendritic cellsWoojong Lee, Brock Kingstad-Bakke, Brett Paulson, et al.
Nature Medicine|November 3, 2023
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trialKen Mautner, Michael Gottschalk, Scott D Boden, et al.
NPJ Regenerative Medicine|November 27, 2025
Label-free in-line characterization of immune cell culture using quantitative phase imagingCaroline E Serafini, Viswanath Gorti, Paloma Casteleiro Costa, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 1, 2017
Alterations to the Gut Microbiome Impair Bone Strength and Tissue Material PropertiesJason D Guss, Michael W Horsfield, Fernanda F Fontenele, et al.
Biorxiv : the Preprint Server for Biology|April 22, 2024
Multi-Niche Human Bone Marrow On-A-Chip for Studying the Interactions of Adoptive CAR-T Cell Therapies with Multiple MyelomaDelta Ghoshal, Ingrid Petersen, Rachel Ringquist, et al.
Biomaterials|December 22, 2024
Multi-niche human bone marrow on-a-chip for studying the interactions of adoptive CAR-T cell therapies with multiple myelomaDelta Ghoshal, Ingrid Petersen, Rachel Ringquist, et al.
Blood|December 10, 2014
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cellsFlorencia Cayrol, María Celeste Díaz Flaqué, Tharu Fernando, et al.
Blood Advances|October 26, 2020
Combined EZH2 and Bcl-2 inhibitors as precision therapy for genetically defined DLBCL subtypesHanna Scholze, Regan E Stephenson, Raymond Reynolds, et al.
Pageof 46